electroCore, Inc.

ROCKAWAY, NJ · Founded 2018 · CIK 0001560258 · Medtech · Public

non-invasive vagus nerve stimulation (nVNS) device for neurology and metabolic disorder treatment

electrocore.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$52M
17 Form D · Apr 2026
6 months since last filing
Contracts
$1.2M
10 awards · Veterans Affairs, Defense
#291 of 4531 in medtech
Patents
40
20 granted · 20 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$500,000
Private capital raisedForm D · SEC$1,500,000
Private capital raisedForm D · SEC$36,000,000
Federal contractDepartment of Veterans Affairs · Gammacore Spapphire Equipment$130,800
Federal contractDepartment of Defense · Solicitation W911S225U0337: Tac-stim$112,575
Private capital raisedForm D · SEC$1,749,999
Private capital raised· 1 of 2 same dayForm D · SEC$1,548,701
Private capital raised· 2 of 2 same dayForm D · SEC$463,678
Federal contractDepartment of Veterans Affairs · Gamma Core Sapphire 3 System$97,640
Private capital raisedForm D · SEC$192,000
Private capital raised· 1 of 2 same dayForm D · SEC$750,000
Private capital raised· 2 of 2 same dayForm D · SEC$52,372
Federal contractDepartment of Defense · Transdermal Vagus Nerve Stimulator$75,000
Federal contractDepartment of Defense · Tac-stim Vagus Nerve Stimulator$502,500
Federal contractDepartment of Veterans Affairs · Gammacore Sapphire$90,000
Private capital raisedForm D · SEC$7,845,000
Federal contractDepartment of Defense · Tac-stim - Non-invasive Vagus Nerve Stimulation Device$15,000
Federal contractDepartment of Defense · 10 Nvns Electrocore Tac-stim 1.0 .$75,000
Federal contractDepartment of Defense · Tac-stim 10020-00301-X1$30,030
Federal contractDepartment of Defense · The Requirement Is For Twelve (12) Tac-stim Non-invasive Vagus Nerve Stimulation (nvns) Cognitive Neuro-enhancement Devices To Support Research And Assessment Of Student Training. 3 Tac-stim Devices Will Be Provided For Research Purposes.$67,575
Private capital raisedForm D · SEC$1,856,000
Federal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
288COURTESY CUPS, LLC$1.2M—
289Cheetah Medical$1.2M$40M
290Genalyte$1.2M—
291electroCore, Inc.$1.2M$52M
292CIVATECH ONCOLOGY, INC.$1.2M$12M
293CLEAR GUIDE MEDICAL, INC.$1.2M$25K
294CLEAR GUIDE MEDICAL, LLC$1.2M$3.6M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 35 related persons
  • Francis AmatoExecutive Officer
  • Frank AmatoDirector · Executive Officer
  • Michael AtiehDirector
  • Robert BertoliniDirector
  • Elena BonfiglioliDirector
  • Nicholas ColucciDirector
  • Nick ColucciDirector
  • Peter CuneoDirector
  • Gordon DonaldDirector
  • Joseph ErricoDirector · Executive Officer
  • JP ErricoDirector · Executive Officer
  • J.P. ErricoDirector · Executive Officer
  • Thomas ErricoDirector
  • Michael FoxExecutive Officer
  • John GandolfoDirector
  • Daniel GoldbergerDirector · Executive Officer
  • Julie GoldsteinDirector
  • Joshua LevExecutive Officer
  • Steve MendezExecutive Officer
  • Trevor MoodyDirector
  • Stephen OndraDirector
  • Thomas PattonDirector
  • Brian PosnerExecutive Officer
  • David RubinDirector
  • Brent SaundersDirector
  • Peter StaatsDirector · Executive Officer
  • Reese TerryDirector
  • Charles TheofilosDirector
  • James TheofilosDirector
  • Kathryn TheofilosDirector
  • James TullisDirector
  • Jim TullisDirector
  • Jeffrey VinikDirector
  • Glenn VraniakExecutive Officer
  • Patricia WilberDirector

Patents

USPTO · 20 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.